These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
35. [Use of guinea pigs for assessing the efficacy of vaccines against Lassa fever]. Firsova IV; Shatokhina IV; Borisevich IV; Evseev AA; Maksimov VA; Pantiukhov VB; Khmelev AL Vopr Virusol; 2003; 48(6):43-5. PubMed ID: 14708232 [TBL] [Abstract][Full Text] [Related]
36. Lassa virus infection of rhesus monkeys: pathogenesis and treatment with ribavirin. Jahrling PB; Hesse RA; Eddy GA; Johnson KM; Callis RT; Stephen EL J Infect Dis; 1980 May; 141(5):580-9. PubMed ID: 6768812 [TBL] [Abstract][Full Text] [Related]
37. A recombinant vesicular stomatitis virus-based Lassa fever vaccine protects guinea pigs and macaques against challenge with geographically and genetically distinct Lassa viruses. Safronetz D; Mire C; Rosenke K; Feldmann F; Haddock E; Geisbert T; Feldmann H PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003736. PubMed ID: 25884628 [TBL] [Abstract][Full Text] [Related]
38. [Evaluation of immune responses and related patho-inflammatory reactions of a candidate inactivated EV71 vaccine in neonatal monkeys]. Zhang XM; Zhao HL; Wang JJ; Liao Y; Na RX; Wang LC; Liu LD; Gao JH; Tang DH; Wang CZ; Li QH Zhonghua Yi Xue Za Zhi; 2011 Jul; 91(28):1977-81. PubMed ID: 22093894 [TBL] [Abstract][Full Text] [Related]
39. Lassa fever: implications of T-cell immunity for vaccine development. ter Meulen J J Biotechnol; 1999 Aug; 73(2-3):207-12. PubMed ID: 10486929 [TBL] [Abstract][Full Text] [Related]
40. Standardization of a plaque assay for Lassa virus. Tomori O; Johnson KM; Kiley MP; Elliott LH J Med Virol; 1987 May; 22(1):77-89. PubMed ID: 3585290 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]